Press Releases

The two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior PFS Engineers, Device Testing Managers, Heads of Late-Stage PFS Development and many more. …
Read More...

Delivery Innovations in Formulation and Device Design for Enhanced Subcutaneous  Injectable Drug devices, London, UK 11th May to 12th May 2022, London, United Kingdom…
Read More...

Assessing device development and regulation for advanced innovation SMi’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA…
Read More...

SMi Group reports: 6th Annual Highly Potent API Conference will return in May 2022 SMi Group has been working the Highly Potent Active Pharmaceutical Ingredients industry for 6 years…
Read More...

SMi Group reports: ahead of the Pain Therapeutics Conference, SMi Group caught up with Andrea Small-Howard, GB Sciences Inc. SMi Group has worked with the Pain Therapeutics industry…
Read More...

Delivery Innovations in Formulation and Device Design for Enhanced Subcutaneous  Injectable Drug devices, London, UK 11th May to 12th May 2022, London, United Kingdom…
Read More...

The microbiome field is making vast breakthroughs within R&D, manufacturing, and consumer product platforms by applying live microbial consortia, engineered microbes, and…
Read More...

On May 17th, 500+ of pharma’s clinical innovation will come together for the home of clinical collaboration, Reuters Events: Pharma Clinical 2022, to set new standards in digital and…
Read More...

SMi Group reports: Key pressing questions on rapid microbial methods, contamination control, sterility assurance and environmental monitoring will be addressed at the Microbiology East…
Read More...

SMi Reports: Chemaxon release an interview prior to joining the SMi’s 3rd Annual AI in Drug Discovery Conference on 14-15 March 2022 in London as a key sponsor. In less than 2 weeks…
Read More...

The countdown has begun for the most prestigious pharmaceutical conclave that is about to kick off in Hyderabad on April 7, 2022.  The last few seats to this dynamic conference…
Read More...

Inhibrx, Inc. announced that the U.S. Food and Drug Administration, or FDA, has granted orphan-drug designation for INBRX-101 for the treatment of alpha-1 antitrypsin deficiency, or…
Read More...

Assessing device development and regulation for advanced innovation SMi’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA…
Read More...

Injectable Drug devices, London, UK 11th May to 12th May 2022, London, United Kingdom www.injectable-drug-delivery.com/ Delivery Innovations in Formulation and Device Design…
Read More...

SMi’s 9th Annual Conference Pre-Filled Syringes East Coast Main Conference: April 25 - 26, 2022 | Workshops: April 27, 2022 Sheraton Boston Hotel, Boston, MA, USA…
Read More...

SMi Presents the 16th Annual Conference: Parallel Trade 2022 Conference Date: 21st – 22nd  March 2022 Workshop date: 23rd March 2022 Website:  www.parallel-trade.com/ Navigating…
Read More...

SMi Group reports: The 22nd Pain Therapeutics Conference welcomes The Pain Society and Eptiva Therapeutics to deliver keynote opening addresses Taking place on 4th to 5th May 2022 in…
Read More...

RNA therapeutics is at a critical stage following the success of the COVID-19 mRNA vaccines. Beyond mRNA vaccines, innovative developments are being made using siRNA, microRNA, tRNA and…
Read More...

SMi Group reports: the key conference sessions during the 6th Annual HPAPi Conference are released SMi's 6th Annual Highly Potent APi Conference will also explore the ADC industry,…
Read More...

11th May to 12th May 2022, London, United Kingdom www.injectable-drug-delivery.com/ Delivery Innovations in Formulation and Device Design for Enhanced Subcutaneous As Part…
Read More...